
develops proprietary, integrated scan, design and print technology designed to deliver custom fit prosthetics, orthotics and orthopedic devices, for an undisclosed sum. The company also reafirms its forecast, saying the acquisition will not be material to
Hanger Orthopedic ( HGR -1.2% ) slips after saying its CEO Thomas Kirk, has decided to retire . In accordance with its succession plan, current President and COO Vinit Asar, has been appointed to succeed Mr. Kirk and has joined the board of directors. Post your comment!
senior management with improved technical expertise. Lindolfo Zimmer became CEO on Jan. 1, 2011. Zimmer was previously at Dobreve Energia S.A., where he served as CEO. Zimmer is no stranger to Copel, holding the positions of chief marketing
May 16 (Reuters) - Medtronic Inc said the Department of Justice and the U.S. Attorney's Office have closed their investigation related to omission of safety issues of its controversial orthopedic ...
May 16 - Standard & Poor's Ratings Services said today that it assigned its 'A-' issue-level rating to Warsaw, Ind.-based orthopedic products maker Zimmer Holdings Inc .'s $1.35 billion senior...
(Reuters) - Mako Surgical Corp lost a third of its market value on Tuesday after the orthopedic device maker posted disappointing quarterly results and lowered its sales forecast for a key product.
MSCI, Avon Products AVP, and Zimmer Holdings ZMH . Frankly, these picks have not ..... MSCI gained 3.85%, while Zimmer shed 2.00%, and Avon fell by ..... The underperformance of MSCI and Zimmer could present a case study in the
Hanger Orthopedic Group ( HGR ): Q1 EPS of $0.22 beats by $0.02 . Revenue of $218M (+8.8% Y/Y) beats by $5M . ( PR ) Post your comment!
Zimmer Holdings ( ZMH ) Q1 2012 Earnings Call April 26, 2012 8:00 am ET Executives David C. Dvorak - Chief Executive Officer, President and Director
April 26 (Reuters) - Orthopedic device maker Zimmer Holdings Inc posted a higher quarterly profit on Thursday, but its shares fell on disappointment that underlying markets for reconstructive implants did not improve more, analysts said.